This inventor holds 3 USPTO granted patents. Top assignees: Sandoz Gmbh, Novartis Ag. Active years: 1983-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983-2002
Title: Heinz Sucker: Innovator in Pharmaceutical Compositions
Introduction
Heinz Sucker is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug delivery systems. With a total of 3 patents to his name, Sucker's work has had a meaningful impact on the industry.
Latest Patents
One of Sucker's latest patents involves pharmaceutical compositions comprised of stabilized peptide particles. This invention focuses on particles of a substantially water-insoluble biologically active substance, such as Cyclosporin. These particles are loaded with a charged glyceryl ester as an electrostatic stabilizer, which imparts a zeta potential to the particles. The active substance to stabilizer weight ratio ranges from 1:1 to 400:1, with an average particle diameter of 1 nanometer to 10 micrometers. Compositions containing such particles are found to be useful delivery systems.
Another significant patent by Sucker is related to hydrosols of pharmacologically active agents. This invention provides a hydrosol of a pharmacological active agent in an intravenous applicable, stabilized, pharmaceutically acceptable form. The hydrosol can be suspended or dry and re-suspendable in an aqueous medium. It contains solid active agent particles, such as dihydropyridines or cyclosporines.
Career Highlights
Throughout his career, Heinz Sucker has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and Novartis AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.
Collaborations
Sucker has collaborated with notable colleagues in his field, including Martin List and Peter Gassmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Heinz Sucker's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical compositions. Sucker's work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile